Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Adicet Bio Inc. Stock

Price
Target price
€0.45

€0.45

-4.820%
-0.0228
-4.820%
-
 
16:51 / Tradegate WKN: A2QESQ / Name: Adicet Bio / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Adicet Bio Inc. in the next few years
Wizard

Adicet Bio Inc. Stock

Heavy losses for Adicet Bio Inc. today as the stock fell by -€0.023 (-4.820%).
Our community identified positive and negative aspects for Adicet Bio Inc. stock for the coming years. 9 users see the criterium "Worthwhile Investment for the next years" as a plus for the Adicet Bio Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
What does Adicet Bio do?

Pros and Cons of Adicet Bio Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Analyzing the financials of Adicet Bio (noted by its U.S. symbol), the overall impression indicates a company grappling with significant challenges. The most glaring issue is the persistent trend of negative net income coupled with a substantial operating loss. Given that the company operates in the biotech sector, this scenario is not uncommon due to the high expenses related to research and development. However, the financial health depicted through balance sheets, cash flows, and key ratios offers a nuanced perspective.

*Pros: *

Strong Cash Reserves: Adicet Bio shows impressive cash reserves at $159.7 million in 2023, shrinking from $257.7 million the previous year but still sufficient for operational needs. This liquidity offers a buffer and provides the flexibility necessary for ongoing research and development projects.

Show more

Comments

Show more
Not a member yet? Sign up for free!